GL1X · GenesisL1 explorer

MolNFT v1 · #37121 · protein

The first ketoreductase of the erythromycin synthase (crystal form 2)

2FR1 · Erythromycin synthase, eryai: “The first ketoreductase of the erythromycin synthase (crystal form 2)”. X-ray diffraction, 1 ligand (NDP), 4 pockets (best druggability 0.74). MolNFT v1 #37121 on GenesisL1: 3D structure, binding sites…

PDB
2FR1
Type
protein
Length
456 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Erythromycin synthase, eryai
EC
1.1.1.100
UniProt
Q03131
Ligands
NDP
Pockets
4 · best druggability 0.74

Structure

x-ray diffraction · 1 distinct chain · 38% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AErythromycin synthase, eryai (EC 1.1.1.100)protein45638% helix, 21% strandQ03131

Ligands and binding sites

  • NDP · Nadph dihydro-nicotinamide-adenine-dinucleotide phosphate · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12800.740.8738empty
22900.560.7640NDP
31180.420.7620empty
4710.350.7722empty

Compared structures

  • 2FR1 · The first ketoreductase of the erythromycin synthase (crystal form 2) · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.